Skip to main content
Erschienen in: Immunologic Research 2/2023

02.11.2022 | Original Article

MiR-29a-3p negatively regulates circulating Tfh memory cells in patients with Graves’ disease by targeting ICOS

verfasst von: Yingzhao Liu, Xuehua Wang, Wenkang Luan, Junli Zou, Jie Xing, Shengjun Wang, Huiyong Peng

Erschienen in: Immunologic Research | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

MicroRNAs (miRNAs) are small endogenous noncoding RNAs that regulate genome expression posttranscriptionally and are involved in autoimmune diseases. Previous studies have indicated that follicular helper T (Tfh) cells play a critical role in the pathogenesis of Graves’ disease (GD). However, the molecular mechanisms that contribute to circulating Tfh memory cell response in GD patients remain incompletely understood. This study aimed to investigate the role of miRNAs on circulating Tfh memory cells in GD patients. Herein, our data showed that the proportion of circulating Tfh memory cells, the transcript levels of IL-21, and the plasma concentrations of IL-21 were increased in the peripheral blood from GD patients. We also found that inducible co-stimulator (ICOS) expression, an important molecule expressed on Tfh cells, were significantly augmented in the peripheral blood mononuclear cells (PBMCs) from GD patients and positively correlated with the percentage of circulating Tfh memory cells and the transcript levels of IL-21 in GD. Intriguingly, miRNA sequencing screened miR-29a-3p expression was downregulated and inversely correlated with ICOS expression and the frequency of circulating Tfh memory cells in patients with GD. Luciferase assay demonstrated that ICOS was the direct target gene of miR-29a-3p, and miR-29a-3p could inhibit ICOS at both transcriptional and translational levels. Overexpression of miR-29a-3p reduced the proportion of circulating Tfh memory cells. Moreover, miR-29a-3p expression negatively correlated with serum concentrations of TSH receptor antibody (TRAb) in GD patients. Collectively, our results demonstrate that miR-29a-3p emerges as a post-transcriptional brake to limit circulating Tfh memory cell response in GD patients and may be involved in the pathogenesis of GD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Weetman AP. Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol. 2003;148:1–9.PubMedCrossRef Weetman AP. Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol. 2003;148:1–9.PubMedCrossRef
2.
Zurück zum Zitat Subekti I, Pramono LA. Current diagnosis and management of Graves' disease. Acta Med Indones. 2018;50:177–82.PubMed Subekti I, Pramono LA. Current diagnosis and management of Graves' disease. Acta Med Indones. 2018;50:177–82.PubMed
5.
Zurück zum Zitat Bartalena L. Diagnosis and management of Graves disease: a global overview. Nat Rev Endocrinol. 2013;9:724–34.PubMedCrossRef Bartalena L. Diagnosis and management of Graves disease: a global overview. Nat Rev Endocrinol. 2013;9:724–34.PubMedCrossRef
6.
8.
Zurück zum Zitat Chen J, Tian J, Tang X, Rui K, Ma J, Mao C, Liu Y, Lu L, Xu H, Wang S. MiR-346 regulates CD4(+)CXCR5(+) T cells in the pathogenesis of Graves' disease. Endocrine. 2015;49:752–60.PubMedCrossRef Chen J, Tian J, Tang X, Rui K, Ma J, Mao C, Liu Y, Lu L, Xu H, Wang S. MiR-346 regulates CD4(+)CXCR5(+) T cells in the pathogenesis of Graves' disease. Endocrine. 2015;49:752–60.PubMedCrossRef
10.
Zurück zum Zitat Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, Lipp M, Forster R. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med. 2000;192:1545–52.PubMedPubMedCentralCrossRef Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, Lipp M, Forster R. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med. 2000;192:1545–52.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Yu D, Walker LSK, Liu Z, Linterman MA, Li Z. Targeting TFH cells in human diseases and vaccination: rationale and practice. Nat Immunol. 2022;23:1157–68.PubMedCrossRef Yu D, Walker LSK, Liu Z, Linterman MA, Li Z. Targeting TFH cells in human diseases and vaccination: rationale and practice. Nat Immunol. 2022;23:1157–68.PubMedCrossRef
12.
Zurück zum Zitat Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, Kroczek RA. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 1999;397:263–6.PubMedCrossRef Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, Kroczek RA. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 1999;397:263–6.PubMedCrossRef
13.
Zurück zum Zitat Haynes NM, Allen CD, Lesley R, Ansel KM, Killeen N, Cyster JG. Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation. J Immunol. 2007;179:5099–108.PubMedCrossRef Haynes NM, Allen CD, Lesley R, Ansel KM, Killeen N, Cyster JG. Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation. J Immunol. 2007;179:5099–108.PubMedCrossRef
14.
Zurück zum Zitat Johnston RJ, Poholek AC, DiToro D, Yusuf I, Eto D, Barnett B, Dent AL, Craft J, Crotty S. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science. 2009;325:1006–10.PubMedPubMedCentralCrossRef Johnston RJ, Poholek AC, DiToro D, Yusuf I, Eto D, Barnett B, Dent AL, Craft J, Crotty S. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science. 2009;325:1006–10.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Nurieva RI, Chung Y, Martinez GJ, Yang XO, Tanaka S, Matskevitch TD, Wang YH, Dong C. Bcl6 mediates the development of T follicular helper cells. Science. 2009;325:1001–5.PubMedPubMedCentralCrossRef Nurieva RI, Chung Y, Martinez GJ, Yang XO, Tanaka S, Matskevitch TD, Wang YH, Dong C. Bcl6 mediates the development of T follicular helper cells. Science. 2009;325:1001–5.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Yu D, Rao S, Tsai LM, Lee SK, He Y, Sutcliffe EL, Srivastava M, Linterman M, Zheng L, Simpson N, Ellyard JI, Parish IA, Ma CS, Li QJ, Parish CR, Mackay CR, Vinuesa CG. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity. 2009;31:457–68.PubMedCrossRef Yu D, Rao S, Tsai LM, Lee SK, He Y, Sutcliffe EL, Srivastava M, Linterman M, Zheng L, Simpson N, Ellyard JI, Parish IA, Ma CS, Li QJ, Parish CR, Mackay CR, Vinuesa CG. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity. 2009;31:457–68.PubMedCrossRef
17.
Zurück zum Zitat Chtanova T, Tangye SG, Newton R, Frank N, Hodge MR, Rolph MS, Mackay CR. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol. 2004;173:68–78.PubMedCrossRef Chtanova T, Tangye SG, Newton R, Frank N, Hodge MR, Rolph MS, Mackay CR. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol. 2004;173:68–78.PubMedCrossRef
18.
Zurück zum Zitat Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, Foucat E, Dullaers M, Oh S, Sabzghabaei N, Lavecchio EM, Punaro M, Pascual V, Banchereau J, Ueno H. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 2011;34:108–21.PubMedPubMedCentralCrossRef Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, Foucat E, Dullaers M, Oh S, Sabzghabaei N, Lavecchio EM, Punaro M, Pascual V, Banchereau J, Ueno H. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 2011;34:108–21.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Lu J, Wu J, Xia X, Peng H, Wang S. Follicular helper T cells: potential therapeutic targets in rheumatoid arthritis. Cell Mol Life Sci. 2021;78:5095–106.PubMedCrossRef Lu J, Wu J, Xia X, Peng H, Wang S. Follicular helper T cells: potential therapeutic targets in rheumatoid arthritis. Cell Mol Life Sci. 2021;78:5095–106.PubMedCrossRef
20.
Zurück zum Zitat Simpson N, Gatenby PA, Wilson A, Malik S, Fulcher DA, Tangye SG, Manku H, Vyse TJ, Roncador G, Huttley GA, Goodnow CC, Vinuesa CG, Cook MC. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum. 2010;62:234–44.PubMedCrossRef Simpson N, Gatenby PA, Wilson A, Malik S, Fulcher DA, Tangye SG, Manku H, Vyse TJ, Roncador G, Huttley GA, Goodnow CC, Vinuesa CG, Cook MC. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum. 2010;62:234–44.PubMedCrossRef
21.
Zurück zum Zitat Liu Y, Yuan X, Li X, Cui D, Xie J. Constitutive changes in circulating follicular helper T cells and their subsets in patients with Graves' disease. J Immunol Res. 2018;2018:8972572.PubMedPubMedCentralCrossRef Liu Y, Yuan X, Li X, Cui D, Xie J. Constitutive changes in circulating follicular helper T cells and their subsets in patients with Graves' disease. J Immunol Res. 2018;2018:8972572.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Dong C, Nurieva RI. Regulation of immune and autoimmune responses by ICOS. J Autoimmun. 2003;21:255–60.PubMedCrossRef Dong C, Nurieva RI. Regulation of immune and autoimmune responses by ICOS. J Autoimmun. 2003;21:255–60.PubMedCrossRef
23.
Zurück zum Zitat Swallow MM, Wallin JJ, Sha WC. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Immunity. 1999;11:423–32.PubMedCrossRef Swallow MM, Wallin JJ, Sha WC. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Immunity. 1999;11:423–32.PubMedCrossRef
24.
Zurück zum Zitat Weber JP, Fuhrmann F, Feist RK, Lahmann A, Al Baz MS, Gentz LJ, Vu Van D, Mages HW, Haftmann C, Riedel R, Grun JR, Schuh W, Kroczek RA, Radbruch A, Mashreghi MF, Hutloff A. ICOS maintains the T follicular helper cell phenotype by down-regulating Kruppel-like factor 2. J Exp Med. 2015;212:217–33.PubMedPubMedCentralCrossRef Weber JP, Fuhrmann F, Feist RK, Lahmann A, Al Baz MS, Gentz LJ, Vu Van D, Mages HW, Haftmann C, Riedel R, Grun JR, Schuh W, Kroczek RA, Radbruch A, Mashreghi MF, Hutloff A. ICOS maintains the T follicular helper cell phenotype by down-regulating Kruppel-like factor 2. J Exp Med. 2015;212:217–33.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Wang F, Yan T, Chen L, Chen X, Liu T, Shen S, Li T, Gao L, Wang T, Sun J, Liu C, Wu H, Zhang X, Chen L. Involvement of inducible costimulator ligand (ICOSL) expression in thyroid tissue in hyperthyroidism of Graves' disease patients. J Clin Immunol. 2012;32:1253–61.PubMedCrossRef Wang F, Yan T, Chen L, Chen X, Liu T, Shen S, Li T, Gao L, Wang T, Sun J, Liu C, Wu H, Zhang X, Chen L. Involvement of inducible costimulator ligand (ICOSL) expression in thyroid tissue in hyperthyroidism of Graves' disease patients. J Clin Immunol. 2012;32:1253–61.PubMedCrossRef
26.
Zurück zum Zitat Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843–54.PubMedCrossRef Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843–54.PubMedCrossRef
27.
Zurück zum Zitat Maul J, Alterauge D, Baumjohann D. MicroRNA-mediated regulation of T follicular helper and T follicular regulatory cell identity. Immunol Rev. 2019;288:97–111.PubMedCrossRef Maul J, Alterauge D, Baumjohann D. MicroRNA-mediated regulation of T follicular helper and T follicular regulatory cell identity. Immunol Rev. 2019;288:97–111.PubMedCrossRef
28.
Zurück zum Zitat Jafarzadeh A, Naseri A, Shojaie L, Nemati M, Jafarzadeh S, Bannazadeh Baghi H, Hamblin MR, Akhlagh SA, Mirzaei H. MicroRNA-155 and antiviral immune responses. Int Immunopharmacol. 2021;101:108188.PubMedCrossRef Jafarzadeh A, Naseri A, Shojaie L, Nemati M, Jafarzadeh S, Bannazadeh Baghi H, Hamblin MR, Akhlagh SA, Mirzaei H. MicroRNA-155 and antiviral immune responses. Int Immunopharmacol. 2021;101:108188.PubMedCrossRef
30.
Zurück zum Zitat Martinez-Hernandez R, Serrano-Somavilla A, Ramos-Levi A, Sampedro-Nunez M, Lens-Pardo A, Munoz De Nova JL, Trivino JC, Gonzalez MU, Torne L, Casares-Arias J, Martin-Cofreces NB, Sanchez-Madrid F, Marazuela M. Integrated miRNA and mRNA expression profiling identifies novel targets and pathological mechanisms in autoimmune thyroid diseases. EBioMedicine. 2019;50:329–42.PubMedPubMedCentralCrossRef Martinez-Hernandez R, Serrano-Somavilla A, Ramos-Levi A, Sampedro-Nunez M, Lens-Pardo A, Munoz De Nova JL, Trivino JC, Gonzalez MU, Torne L, Casares-Arias J, Martin-Cofreces NB, Sanchez-Madrid F, Marazuela M. Integrated miRNA and mRNA expression profiling identifies novel targets and pathological mechanisms in autoimmune thyroid diseases. EBioMedicine. 2019;50:329–42.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Yin L, Zeng C, Yao J, Shen J. Emerging roles for noncoding RNAs in autoimmune thyroid disease. Endocrinology. 2020;161. Yin L, Zeng C, Yao J, Shen J. Emerging roles for noncoding RNAs in autoimmune thyroid disease. Endocrinology. 2020;161.
32.
Zurück zum Zitat Yao Q, Wang X, He W, Song Z, Wang B, Zhang J, Qin Q. Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease. Endocrine. 2019;65:102–9.PubMedCrossRef Yao Q, Wang X, He W, Song Z, Wang B, Zhang J, Qin Q. Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease. Endocrine. 2019;65:102–9.PubMedCrossRef
33.
Zurück zum Zitat Liu Y, Ding X, Xiong S, Wang X, Tang X, Wang L, Wang S, Peng H. Circulating microRNA expression profiling identifies miR-125a-5p promoting T helper 1 cells response in the pathogenesis of Hashimoto's thyroiditis. Front Immunol. 2020;11:1195.PubMedPubMedCentralCrossRef Liu Y, Ding X, Xiong S, Wang X, Tang X, Wang L, Wang S, Peng H. Circulating microRNA expression profiling identifies miR-125a-5p promoting T helper 1 cells response in the pathogenesis of Hashimoto's thyroiditis. Front Immunol. 2020;11:1195.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Luthje K, Kallies A, Shimohakamada Y, Belz GT, Light A, Tarlinton DM, Nutt SL. The development and fate of follicular helper T cells defined by an IL-21 reporter mouse. Nat Immunol. 2012;13:491–8.PubMedCrossRef Luthje K, Kallies A, Shimohakamada Y, Belz GT, Light A, Tarlinton DM, Nutt SL. The development and fate of follicular helper T cells defined by an IL-21 reporter mouse. Nat Immunol. 2012;13:491–8.PubMedCrossRef
36.
Zurück zum Zitat Weber JP, Fuhrmann F, Hutloff A. T-follicular helper cells survive as long-term memory cells. Eur J Immunol. 2012;42:1981–8.PubMedCrossRef Weber JP, Fuhrmann F, Hutloff A. T-follicular helper cells survive as long-term memory cells. Eur J Immunol. 2012;42:1981–8.PubMedCrossRef
37.
38.
Zurück zum Zitat Rapoport B, McLachlan SM. Graves' hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease. J Clin Endocrinol Metab. 2014;99:4060–1.PubMedPubMedCentralCrossRef Rapoport B, McLachlan SM. Graves' hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease. J Clin Endocrinol Metab. 2014;99:4060–1.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Cai Y, Wang Z, Liu X, Wei L, Li S, Zheng X, Yang T, Xu X. The frequency of intrathyroidal follicular helper T cells varies with the progression of Graves' disease and Hashimoto's thyroiditis. J Immunol Res. 2022;2022:4075522.PubMedPubMedCentralCrossRef Cai Y, Wang Z, Liu X, Wei L, Li S, Zheng X, Yang T, Xu X. The frequency of intrathyroidal follicular helper T cells varies with the progression of Graves' disease and Hashimoto's thyroiditis. J Immunol Res. 2022;2022:4075522.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Zhang J, Ren M, Zeng H, Guo Y, Zhuang Z, Feng Z, Yan H, Xu M, Liang W, Yang C, Cheng H, Ding H, Yan L. Elevated follicular helper T cells and expression of IL-21 in thyroid tissues are involved in the pathogenesis of Graves' disease. Immunol Res. 2015;62:163–74.PubMedCrossRef Zhang J, Ren M, Zeng H, Guo Y, Zhuang Z, Feng Z, Yan H, Xu M, Liang W, Yang C, Cheng H, Ding H, Yan L. Elevated follicular helper T cells and expression of IL-21 in thyroid tissues are involved in the pathogenesis of Graves' disease. Immunol Res. 2015;62:163–74.PubMedCrossRef
41.
Zurück zum Zitat Zhu C, Ma J, Liu Y, Tong J, Tian J, Chen J, Tang X, Xu H, Lu L, Wang S. Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab. 2012;97:943–50.PubMedCrossRef Zhu C, Ma J, Liu Y, Tong J, Tian J, Chen J, Tang X, Xu H, Lu L, Wang S. Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab. 2012;97:943–50.PubMedCrossRef
42.
Zurück zum Zitat Qi Y, Zhou Y, Chen X, Ye L, Zhang Q, Huang F, Cui B, Lin D, Ning G, Wang W, Wang S. MicroRNA-4443 causes CD4+ T cells dysfunction by targeting TNFR-associated factor 4 in Graves' disease. Front Immunol. 2017;8:1440.PubMedPubMedCentralCrossRef Qi Y, Zhou Y, Chen X, Ye L, Zhang Q, Huang F, Cui B, Lin D, Ning G, Wang W, Wang S. MicroRNA-4443 causes CD4+ T cells dysfunction by targeting TNFR-associated factor 4 in Graves' disease. Front Immunol. 2017;8:1440.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Sun Y, Wang W, Tang Y, Wang D, Li L, Na M, Jiang G, Li Q, Chen S, Zhou J. Microarray profiling and functional analysis of differentially expressed plasma exosomal circular RNAs in Graves' disease. Biol Res. 2020;53:32.PubMedPubMedCentralCrossRef Sun Y, Wang W, Tang Y, Wang D, Li L, Na M, Jiang G, Li Q, Chen S, Zhou J. Microarray profiling and functional analysis of differentially expressed plasma exosomal circular RNAs in Graves' disease. Biol Res. 2020;53:32.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Xu H, Li X, Liu D, Li J, Zhang X, Chen X, Hou S, Peng L, Xu C, Liu W, Zhang L, Qi H. Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature. 2013;496:523–7.PubMedCrossRef Xu H, Li X, Liu D, Li J, Zhang X, Chen X, Hou S, Peng L, Xu C, Liu W, Zhang L, Qi H. Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature. 2013;496:523–7.PubMedCrossRef
45.
Zurück zum Zitat Gigoux M, Shang J, Pak Y, Xu M, Choe J, Mak TW, Suh WK. Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase. Proc Natl Acad Sci U S A. 2009;106:20371–6.PubMedPubMedCentralCrossRef Gigoux M, Shang J, Pak Y, Xu M, Choe J, Mak TW, Suh WK. Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase. Proc Natl Acad Sci U S A. 2009;106:20371–6.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Yan J, Zhang X, Sun S, Yang T, Yang J, Wu G, Qiu Y, Yin Y, Xu W. miR-29b Reverses T helper 1 cells/T helper 2 cells imbalance and alleviates airway eosinophils recruitment in OVA-induced murine asthma by targeting inducible co-stimulator. Int Arch Allergy Immunol. 2019;180:182–94.PubMedCrossRef Yan J, Zhang X, Sun S, Yang T, Yang J, Wu G, Qiu Y, Yin Y, Xu W. miR-29b Reverses T helper 1 cells/T helper 2 cells imbalance and alleviates airway eosinophils recruitment in OVA-induced murine asthma by targeting inducible co-stimulator. Int Arch Allergy Immunol. 2019;180:182–94.PubMedCrossRef
47.
Zurück zum Zitat Pratama A, Srivastava M, Williams NJ, Papa I, Lee SK, Dinh XT, Hutloff A, Jordan MA, Zhao JL, Casellas R, Athanasopoulos V, Vinuesa CG. MicroRNA-146a regulates ICOS-ICOSL signalling to limit accumulation of T follicular helper cells and germinal centres. Nat Commun. 2015;6:6436.PubMedCrossRef Pratama A, Srivastava M, Williams NJ, Papa I, Lee SK, Dinh XT, Hutloff A, Jordan MA, Zhao JL, Casellas R, Athanasopoulos V, Vinuesa CG. MicroRNA-146a regulates ICOS-ICOSL signalling to limit accumulation of T follicular helper cells and germinal centres. Nat Commun. 2015;6:6436.PubMedCrossRef
48.
Zurück zum Zitat Li J, Wan Y, Guo Q, Zou L, Zhang J, Fang Y, Zhang J, Zhang J, Fu X, Liu H, Lu L, Wu Y. Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res Ther. 2010;12:R81.PubMedPubMedCentralCrossRef Li J, Wan Y, Guo Q, Zou L, Zhang J, Fang Y, Zhang J, Zhang J, Fu X, Liu H, Lu L, Wu Y. Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res Ther. 2010;12:R81.PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC, Li PK, Szeto CC. Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J Rheumatol. 2010;37:2516–22.PubMedCrossRef Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC, Li PK, Szeto CC. Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J Rheumatol. 2010;37:2516–22.PubMedCrossRef
50.
Zurück zum Zitat Cron MA, Payet CA, Fayet OM, Maillard S, Truffault F, Fadel E, Guihaire J, Berrih-Aknin S, Liston A, Le Panse R. Decreased expression of miR-29 family associated with autoimmune myasthenia gravis. J Neuroinflammation. 2020;17:294.PubMedPubMedCentralCrossRef Cron MA, Payet CA, Fayet OM, Maillard S, Truffault F, Fadel E, Guihaire J, Berrih-Aknin S, Liston A, Le Panse R. Decreased expression of miR-29 family associated with autoimmune myasthenia gravis. J Neuroinflammation. 2020;17:294.PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Soh SB, Aw TC. Laboratory testing in thyroid conditions – pitfalls and clinical utility. Ann Lab Med. 2019;39:3–14.PubMedCrossRef Soh SB, Aw TC. Laboratory testing in thyroid conditions – pitfalls and clinical utility. Ann Lab Med. 2019;39:3–14.PubMedCrossRef
Metadaten
Titel
MiR-29a-3p negatively regulates circulating Tfh memory cells in patients with Graves’ disease by targeting ICOS
verfasst von
Yingzhao Liu
Xuehua Wang
Wenkang Luan
Junli Zou
Jie Xing
Shengjun Wang
Huiyong Peng
Publikationsdatum
02.11.2022
Verlag
Springer US
Erschienen in
Immunologic Research / Ausgabe 2/2023
Print ISSN: 0257-277X
Elektronische ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-022-09333-5

Weitere Artikel der Ausgabe 2/2023

Immunologic Research 2/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.